BOSTON--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it was granted the
American Podiatric Medical Association (APMA) Seal of Approval for its
Quell Wearable Pain Relief device.
"The APMA Seal of Approval is awarded after a rigorous scientific review
by a group of APMA member podiatrists. The committee examines
information about the product's safety, quality control, and other
data," said APMA Executive Director Dr. Jim Christina. "Quell received
the APMA Seal of Approval which is granted to products found to be
effective and promote good foot health."
Quell is an easy-to-use, over-the-counter device for chronic pain
relief. The wearable device utilizes NeuroMetrix's wearable intensive
nerve stimulation (WINS) technology to provide pain relief. In a recent
clinical study, 81 percent of participants reported improvement with
chronic pain and overall health after using Quell. Quell is available
through select healthcare professionals and retailers.
"We are proud to have Quell recognized by APMA," said Shai Gozani, MD,
PhD, President and CEO NeuroMetrix. "We know that the APMA sets a high
standard for products that earn its Seal of Approval and are honored by
their recognition of Quell as a 100% drug free option that is FDA
cleared for day and night use for people with chronic pain. Quell was
designed to meet the needs of people with various forms of chronic pain
such as foot and leg pain, nerve pain, fibromyalgia pain, back pain and
arthritic pain."
NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
APMA
The American Podiatric Medical Association (APMA) is the nation's
leading professional organization for today's podiatrists. Doctors of
Podiatric Medicine (DPMs) are qualified by their education, training,
and experience to diagnose and treat conditions affecting the foot,
ankle, and structures of the leg. APMA has 53 state component locations
across the United States and its territories, with a membership of more
than 12,000 podiatrists. All practicing APMA members are licensed by the
state in which they practice podiatric medicine. For more information,
visit www.apma.org.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151111006231/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
